alert icon Important Updates + Notice of Vendor Data Event

Coming to a Cleveland Clinic location?
Hillcrest Cancer Center check-in changes
Cole Eye entrance closing
Visitation and COVID-19 information

Notice of Intelligent Business Solutions data event
Learn more

Notice of MedInform data event
Learn more

Susan Rehm, MD

Susan Rehm, MD
  • Watch Video
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Infectious Disease
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus


Additional Locations

Specialties & Treatments

Treatment & Services

  • Infectious Disease Consultation
  • Infectious Disease Treatment
  • Outpatient Antibiotic Therapy
  • Outpatient Intravenous Antibiotic Treatment
View all 4 Treatment & Services +

Specialty in Diseases & Conditions

  • Bacteremia
  • Endocarditis
  • General Infectious Diseases
  • Infective Endocarditis
  • Sepsis
  • Staphylococcus Aureus Infections
View all 6 Specialties +


Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About Susan Rehm, MD

Susan J. Rehm, MD, is Vice Chair of the Department of Infectious Disease and Executive Director of Physician Health at Cleveland Clinic.

Throughout her career, Dr. Rehm has been active in medical education, previously serving as Program Director for the Cleveland Clinic’s Infectious Disease Fellowship and its Internal Medicine Residency Program. Since 2005, Dr. Rehm has served as Medical Director for the National Foundation for Infectious Diseases, a nonprofit organization dedicated to the education of professionals and the public about the causes and treatment of infectious diseases.

Dr. Rehm’s clinical research interest is in Dr. Rehm’s clinical research interest is in  endocarditis and infected cardiac devices. In addition to participation in clinical trials of newer antimicrobial agents, she is involved in outcomes studies. Administration of parenteral antibiotics outside the hospital setting is an ongoing clinical and research focus.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Fellowship - Cleveland Clinic
Infectious Disease
Cleveland, OH USA

Residency - Cleveland Clinic
Internal Medicine
Cleveland, OH USA

Internship - Cleveland Clinic
Internal Medicine
Cleveland, OH USA

Medical Education - University of Nebraska College of Medicine
Omaha, NE USA

Undergraduate - University of Nebraska
Lincoln, NE USA

Professional Highlights

  • Medical Director, National Foundation for Infectious Diseases


  • Internal Medicine
  • Internal Medicine - Infectious Disease

Specialty Interests

new antibiotics, outpatient intravenous antibiotic treatment, Staphylococcus Aureus Infections

Awards & Honors

  • Best Doctors in America, 2002-Present

Innovations & Patents

  • Dr. Rehm established Cleveland Clinic's community parenteral antibiotic therapy (CoPAT) program in 1982. This program allows patients to receive intravenous antibiotics outside the hospital. Patients are able to recuperate in familiar surroundings, and some may return to work or school while receiving IV antibiotic therapy.


  • Infectious Diseases Society of America
  • American College of Physicians
  • American Society for Microbiology
  • American Medical Association
  • American College of Physician Executives
Research & Publications

Research & Publications

See publications for Susan Rehm, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 2/7/2023, Dr. Rehm has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Back to Top